Duality Biotherapeutics, Inc. (HKG:9606)

Duality Biotherapeutics Revenue

Duality Biotherapeutics had revenue of 219.33M CNY in the half year ending June 30, 2026, a decrease of -78.06%. This brings the company's revenue in the last twelve months to 842.13M, down -61.20% year-over-year. In the year 2025, Duality Biotherapeutics had annual revenue of 1.85B, down -4.61%.

• Revenue (ttm): 842.13M CNY
• Revenue Growth: -61.20%
• P/S Ratio: 18.79
• Revenue / Employee: 3.17M CNY
• Employees: 266
• Market Cap: 18.27B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.85B	-89.52M	-4.61%
Dec 31, 2024	1.94B	154.72M	8.66%
Dec 31, 2023	1.79B	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 30, 2026

Data Sources Report a data error